Clinical Trials Browser

Interventional × Small Cell Lung Carcinoma × LY3295668 erbumine × Clear all

NCT03898791 2021-08-05

A Study of LY3295668 Erbumine in Participants With Extensive-stage Small-Cell Lung Cancer

Phase 1 Completed

Epilepsy, Small Cell Lung Carcinoma